Bariatric procedures and changes in gut hormones and gastric passage

Bariatric procedures and changes in gut hormones and gastric passage - BIP-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44151

Enrollment

Registered

2017-11-02

Start date

2018-10-09

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric emptying hormonal changes

Interventions

Bariatric surgery

Gastric emptying

Incretins

Roux-en-Y gastric bypass

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Age > 18 years - Patient underwent a standard RYGB (S-RYGB), B-RYGB or EP-RYGB and is a mean responder (clinic mean Excess Weight Loss +/- 10% or mean Total Body Weight Loss +/- 5%). - Patient is able to adhere to the study visit schedule and protocol requirements - Patient is able to give informed consent and the consent must be obtained prior to any study procedures - Patient had a follow-up period of at least one year after S-RYGB, B-RYGB or EP-RYGB without any complications

Exclusion criteria

Exclusion criteria: - Binge-eating or associated eating disorder - Active drug or alcohol addiction - Pregnancy and when giving breast feeding - Gluten allergy - Inability to stop medication that affects the motility of the upper gastrointestinal tract (anti-cholinergic drugs, prokinetics, theophylline, calcium blocking agents, opioids) - Endocrine disease influencing gastric emptying (diabetes mellitus, hyper- or hypothyroidism)

Design outcomes

Primary

Measure	Time frame
Gastric emptying rate and gut hormone levels in patients one year after S-RYGB, B-RYGB and EP-RYGB.	—

Secondary

Measure	Time frame
Excess weight loss (%EWL)	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)